Author Archives: Edward J. Gane, Robert H. Hyland, Di An, Evguenia Svarovskaia, Phillip S. Pang, Diana Brainard, Catherine A. Stedman
Efficacy of Ledipasvir and Sofosbuvir, With or Without Ribavirin, for 12 Weeks in Patients With HCV Genotype 3 or 6 Infection
We performed a phase 2 clinical trial to evaluate the efficacy and safety of ledipasvir and sofosbuvir, with or without ribavirin, in patients infected with HCV genotype 3 or 6. Continue reading
Posted in News
Comments Off on Efficacy of Ledipasvir and Sofosbuvir, With or Without Ribavirin, for 12 Weeks in Patients With HCV Genotype 3 or 6 Infection